Clear Labelling Of Industrial & Medical Oxygen Must, PMO Tells Health Ministry

New Delhi:  The Prime Minister’s Office (PMO) has written to the health ministry to take necessary action regarding the labelling of oxygen cylinders to differentiate between industrial and medical oxygen after lawmaker Ajeet Madhavrao Gopchade raised the need to do so in the interest of patients.

“I brought this to the notice of the PMO. As a doctor, I understand it is a critical issue and needs attention. To protect patients, even the World Health Organization has released guidelines on the quality of medical oxygen,” Gopchade told ET.

“Throughout the Covid pandemic, it was noted that a significant number of patients who needed external oxygen support acquired a fungal infection. Unfortunately, many individuals lost their eyesight as a result. There seems to be a lack of focus from the state and central government on guaranteeing the quality of medical oxygen. There is a shortage of clear labelling on oxygen cylinders to differentiate between industrial and medical oxygen,” the lawmaker said in his letter to the PMO.

He urged the PMO to instruct the relevant authorities to issue advisory to state governments directing them to ensure the quality of medical oxygen and conduct mandatory inspections of medical oxygen production facilities.

Taking cognizance of the issue, the PMO has written to the health ministry directing it “to take action as deemed appropriate”.

In India, the Ministry of Health and Family Welfare (MoHFW) and the Department for Promotion of Industry and Internal Trade (DPIIT) are responsible for managing the supply of medical oxygen in India. While the health ministry develops guidelines for setting up oxygen plants, DPIIT manages the supply of medical oxygen, including drugs and equipment.

Different industries, including health systems, use oxygen on a regular basis. According to the WHO, medical-use oxygen is very different from industrial oxygen in purity and quality. “Thus, industrial and medical use (oxygen) are not interchangeable,” says the WHO document.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit